TD Cowen Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Brendan Smith maintains a Buy rating on Ginkgo Bioworks Holdings (NYSE:DNA) and raises the price target from $3 to $10.
September 20, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Brendan Smith has reaffirmed a Buy rating for Ginkgo Bioworks Holdings and significantly increased the price target from $3 to $10, indicating strong confidence in the company's future performance.
The analyst's decision to maintain a Buy rating and raise the price target significantly suggests a positive outlook for Ginkgo Bioworks. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100